Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD)

Acta Ophthalmologica

Volumn 89, Issue 7, 2011, Pages

  Tsika, Chrysanthi ^a,b   Tsilimbaris, Miltiadis K ^a,b   Makridaki, Maria ^c   Kontadakis, Georgios ^b   Plainis, Sotiris ^b   Moschandreas, Joanna ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

age related macular degeneration; heterochromatic flicker photometry; lutein; macular pigment optical density; wet AMD; zeaxanthin

Indexed keywords

VISUAL PIGMENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRITICAL FLICKER FUSION; EXUDATIVE MACULAR DEGENERATION; EYE COLOR; FEMALE; GEOGRAPHIC ATROPHY; HUMAN; MACULAR PIGMENT OPTICAL DENSITY; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PERIPHERAL VISION; PHOTOMETRY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SEX DIFFERENCE; SMOKING;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GEOGRAPHIC ATROPHY; HUMANS; INTRAOCULAR PRESSURE; LUTEIN; MALE; MIDDLE AGED; PHOTOMETRY; RETINAL PIGMENTS; VISUAL ACUITY; WET MACULAR DEGENERATION; XANTHOPHYLLS;

EID: 80255137407     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02170.x     Document Type: Article

References (52)

1. Age-Related Eye Disease Study Research Group (2001a): A randomized, placebo- controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss-Report Number 8. Arch Ophthalmol 119: 1417-1435.
2. Age-Related Eye Disease Study Research Group (2001b): A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss-Report Number 9. Arch Ophthalmol 119: 1439-1452.
3. Age-Related Eye Disease Study Research Group (2001c): Results from the Age-Related Eye Disease Study. Booklet of AREDS I.
4. Beatty S, Koh H-H, Carden D, &, Murray IJ, (2000a): Macular pigment optical density measurement: a novel compact instrument. Ophthalmic Physiol Opt 20: 105-111. (Pubitemid 30122823)
5. Beatty S, Koh HH, Henson D, &, Boulton M, (2000b): The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134.
6. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, &, Boulton M, (2001): Macular pigment and risk of age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci 42: 439-446. (Pubitemid 32121477)
7. Beatty S, van Kuijk FJGM, &, Chakravarthy U, (2008): Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed. Invest Ophthalmol Vis Sci 49: 843-845.
8. Berendschot TTJM, &, van Norren D, (2004): Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch Biochem Biophys 430: 149-155. (Pubitemid 39208961)
9. Berendschot TTJM, &, van Norren D, (2005): On the age dependency of the macular pigment optical density. Exp Eye Res 81: 602-609. (Pubitemid 41532005)
10. Berendschot TTJM, Willemse-Assink JJM, Bastiaanse M, de Jong PTVM, &, van Norren D, (2002): Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43: 1928-1932. (Pubitemid 34587043)
11. Bone RA, &, Landrum JT, (2004): Heterochromatic flicker photometry. Arch Biochem Biophys 430: 137-142. (Pubitemid 39208959)
12. Bone RA, Landrum JT, Fernandez L, &, Tarsis SL, (1988): Analysis of the MP by HPLC retinal distribution and age study. Invest Ophthalmol Vis Sci 29: 843-849.
13. Bone RA, Landrum JT, Guerra LH, &, Ruiz CA, (2003): Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133: 992-998. (Pubitemid 36407115)
14. Ciulla TA, &, Hammond BR, (2004): Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol 138: 582-587. (Pubitemid 39420485)
15. Curran-Celentano J, Hammond BR Jr, Ciulla TA, Cooper DA, Pratt LM, &, Danis RB, (2001): Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 74: 796-802. (Pubitemid 33101801)
16. Darzins P, Mitchell P, &, Heller RF, (1997): Sun exposure and age-related macular degeneration: an Australian case-control study. Ophthalmology 104: 770-776. (Pubitemid 27200873)
17. Delori FC, (2004): Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys 430: 156-162. (Pubitemid 39208962)
18. Delori FC, Goger DG, Hammond BR, Snodderly DM, &, Burns SA, (2001): Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18: 1212-1230.
19. Friedman E, (1997): A haemodynamic model of the pathogenesis of age- related macular degeneration. Am J Ophthalmol 124: 677-682.
20. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K, &, Gragoudas ES, (1995): Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 102: 640-646.
21. Grunwald JE, Metelitsina TI, DuPont JC, Ying G-S, &, Maguire MG, (2005): Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci 46: 1033-1038. (Pubitemid 41321042)
22. Hammond BR Jr, &, Caruso-Avery M, (2000): Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41: 1492-1497. (Pubitemid 30261875)
23. Hammond BR Jr, Curran-Celentano J, Judd S, Fuld K, Krinsky NI, Wooten BR, &, Snodderly DM, (1996a): Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res 36: 2001-2012. (Pubitemid 26192671)
24. Hammond BR Jr, Wooten BR, &, Snodderly DM, (1996b): Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res 36: 3003-3009. (Pubitemid 26326610)
25. Hammond BR Jr, Ciulla TA, &, Snodderly DM, (2002): Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci 43: 47-50. (Pubitemid 34032439)
26. Hammond BR Jr, Wooten BR, &, Smollon B, (2005): Assessment of the validity of in vivo methods of measuring human macular pigment optical density. Optom Vis Sci 82: 387-404. (Pubitemid 40664335)
27. Iannaccone A, Mura M, Gallaher KT, et al., (2007): Macular pigment optical density in the elderly: findings in a large biracial midsouth population sample. Invest Ophthalmol Vis Sci 48: 1458-1465. (Pubitemid 351261325)
28. Kanis M, Berendschot TTJM, &, van Norren D, (2007): Influence of macular pigment and melanin on incident early AMD in a white population. Graefes Arch Clin Exp Ophthalmol 245: 767-773. (Pubitemid 46805605)
29. Koh H-H, Murray IJ, Nolan D, Carden D, Feather J, &, Beatty S, (2004): Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 79: 21-27. (Pubitemid 38737379)
30. LaRowe TL, Mares JA, Snodderly DM, &, Klein ML, (2008): Macular pigment density and Age-Related Maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the Women's Health Initiative. Ophthalmology 115: 876-883.
31. Leung IY-F, &, Phil M, (2008): Macular pigment: new clinical methods of detection and the role of carotenoids in age-related macular degeneration. Optometry 79: 266-272.
32. Liew SM, Gilbert CE, Spector TD, Beatty S, van Kuijk FJ, Mellerio J, Marshall J, &, Hammond CJ, (2005): Macular pigment heritability: a twin study. Invest Ophthalmol Vis Sci 46: 4430-4436. (Pubitemid 44264535)
33. Makridaki M, Carden D, &, Murray IJ, (2009): Macular pigment measurement in clinics: controlling the effect of the ageing media. Ophthalmic Physiol Opt 29: 338-344.
34. Nolan J, O'Donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A, Mellerio J, &, Beatty S, (2004): Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 45: 3940-3950. (Pubitemid 39411145)
35. Nolan JM, Stack J, O'Donovan O, Loane E, &, Beatty S, (2007): Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84: 61-74. (Pubitemid 44792053)
36. Nolan JM, Kenny R, O'Regan C, et al., (2010): Macular pigment optical density in an ageing Irish population: the Irish Longitudinal Study on Ageing. Ophthalmic Res 44: 131-139.
37. Pournaras CJ, Logean E, Riva CE, Petrig BL, Chamot SR, Coscas G, &, Soubrane G, (2006): Regulation of subfoveal choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 47: 1581-1586. (Pubitemid 46780768)
38. Snodderly DM, (1995): Evidence for protection against age-related macular degeneration by carotenoids and anti-oxidant vitamins. Am J Clin Nutr 62 (Suppl.): 1448S-1461S.
39. Snodderly DM, Auran JD, &, Delori FC, (1984): The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25: 674-685. (Pubitemid 14082977)
40. Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T, & for the CAREDS Macular Pigment Study Group (2004): Macular pigment measurement by heterochromatic flicker photometry in older subjects: the Carotenoids and Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci 45: 531-538. (Pubitemid 38140511)
41. Sommerburg O, Keunen JEE, Bird AC, &, van Kuijk FJGM, (1998): Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 82: 907-910. (Pubitemid 28408149)
42. Sparrow JR, &, Cai B, (2001): Blue light-induced apoptosis of A2E- containing RPE: involvement ofcaspase-3 and protection byBcl-2. Invest Ophthalmol Vis Sci 42: 1356-1362. (Pubitemid 32381981)
43. Stahl W, &, Sies H, (2003): Antioxidant activity of carotenoids. Mol Aspects Med 24: 345-351. (Pubitemid 37324647)
44. Stahl W, Nicolai S, Briviba K, Hamusch M, Broszeit G, Peters M, Martin H-D, &, Sie H, (1997): Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching. Carcinogenesis 18: 89-92. (Pubitemid 28134620)
45. Stringham JM, Hammond BR, Nolan JM, Wooten BR, Mammen A, Smollon W, &, Snodderly DM, (2008): The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res 87: 445-453.
46. Tan JSL, Wang JJ, Flood V, Rochtchina E, Smith W, &, Mitchell P, (2008): Dietary antioxidants and the long-term incidence of age-related macular degeneration, The Blue Mountains Eye Study. Ophthalmology 115: 334-341. (Pubitemid 351175680)
47. Taylor HR, West S, Munoz B, Rosenthal FS, Bressler SB, &, Bressler NM, (1992): The long-term effects of visible light on the eye. Arch Ophthalmol 110: 99-104.
48. Van der Veen RLP, Berendschot TJM, Hendrikse F, Carden D, Makridaki M, &, Murray I, (2009): A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt 29: 127-137.
49. West SK, Rosenthal FS, Bressler NM, Munoz B, Fine SL, &, Taylor HR, (1989): Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 107: 875-879. (Pubitemid 19166363)
50. Wolf-Schnurrbusch UEK, Röösli N, Weyermann E, Heldner MR, Höhne K, &, Wolf S, (2007): Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci 48: 3783-3787. (Pubitemid 351261118)
51. Wooten BR, Hammond BR Jr, Land RI, &, Snodderly DM, (1999): A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 40: 2481-2489. (Pubitemid 29455474)
52. Zhao J, Frambach DA, Lee PR, Lee M, &, Lopez PF, (1995): Delayed macular choriocapillary circulation in age-related macular degeneration. Int Ophthalmol 19: 1-12.